Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
| Autor: | Mavroudis, D. *, Matikas, A., Malamos, N., Papakotoulas, P., Kakolyris, S., Boukovinas, I., Athanasiadis, A., Kentepozidis, N., Ziras, N., Katsaounis, P., Saloustros, E., Georgoulias, V. |
|---|---|
| Zdroj: | In Annals of Oncology October 2016 27(10):1873-1878 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|